Crosstalk between NGS Receptors, TrkA & P75

NGS 受体之间的串扰,TrkA

基本信息

  • 批准号:
    7561067
  • 负责人:
  • 金额:
    $ 32.78万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2000
  • 资助国家:
    美国
  • 起止时间:
    2000-09-30 至 2011-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Neurotrophins play key regulatory roles in cellular processes that are required for proper development and maintenance of the nervous system, such as cell survival/death, axon growth/guidance, and synaptic transmission/plasticity. Both Trk receptors and p75 participate in mediating these diverse neurotrophin actions, but p75 is mainly responsible for neurotrophin-dependent cell death at specific stages during development or under pathological conditions in the adult. The overall goal of this project is to understand the signaling mechanisms that underlie NGF's action regarding cell death and survival, with a focus on Rac and Rho, which are regulated by p75. P75 activates Rac in a prolonged manner that correlates with apoptosis, while co-activation of Trk/p75 leads to transient Rac activation and cell survival. These results suggest that the kinetics of Rac activation may be the key determinant in cellular outcome between cell survival and death. Regulation of Rho, on the other hand, may be determined by which coreceptor that p75 associates with: With neurotrophins/Trk, p75 inhibits Rho, while it activates Rho as a co-receptor for the Nogo receptor, NgR. P75 is often induced by injury in the adult nervous system and its expression in such cases has been linked to apoptosis. After the experimental injuries that induced p75 and cell death, Rho was activated, suggesting that controlling Rho activation by p75 will be critical in preventing cell death and degeneration after injuries. Our overall hypothesis is therefore that regulation of Rac and Rho by p75 determines the outcome between cell death and survival/regeneration. In an effort to understand the mechanisms by which p75 activates Rac and Rho, we discovered that the Kalirin family of guanidine exchange factors (GEF), Kalirin7 and 9, bind p75. Kalirin7 contains a Rac GEF domain, while Kalirin9 contains both Rac and Rho GEF domains. The specific aims include: (1) To determine the mechanisms of transient Rac activation by Kalirin7, (2) To determine whether prolonged Rac activation is necessary for apoptosis, and (3) To determine whether Kalirin9 is responsible for regulating the opposite's action of p75 for Rho activity both in vitro and in vivo after spinal cord injury. The outcome of this study will result in significant advancement of the current knowledge of NGF signaling, by elucidating the basic biochemical mechanisms behind the complex interplay between p75 and Trk, as well as p75 and NgR. A detailed understanding of the mechanisms may ultimately prompt therapeutic strategies for promoting regeneration and limiting degeneration in cases of neuronal injury and disease.
描述(由申请人提供):神经营养因子在神经系统正常发育和维持所需的细胞过程中发挥关键的调节作用,例如细胞存活/死亡,轴突生长/引导和突触传递/可塑性。Trk受体和p75都参与介导这些不同的神经营养因子作用,但p75主要负责在发育的特定阶段或成人病理条件下神经营养因子依赖性细胞的死亡。该项目的总体目标是了解NGF在细胞死亡和存活方面的作用的信号机制,重点关注由p75调节的Rac和Rho。P75激活Rac的时间较长,与细胞凋亡有关,而Trk/ P75的共激活导致Rac的短暂激活和细胞存活。这些结果表明,Rac活化动力学可能是细胞存活和死亡之间细胞结局的关键决定因素。另一方面,Rho的调节可能取决于p75与哪个辅助受体相关:与神经营养因子/Trk一起,p75抑制Rho,而它激活Rho作为Nogo受体NgR的辅助受体。P75通常由成人神经系统损伤引起,在这种情况下,P75的表达与细胞凋亡有关。在诱导p75和细胞死亡的实验损伤后,Rho被激活,这表明通过p75控制Rho的激活对于防止损伤后细胞死亡和变性至关重要。因此,我们的总体假设是p75对Rac和Rho的调控决定了细胞死亡和存活/再生之间的结果。为了了解p75激活Rac和Rho的机制,我们发现Kalirin家族的胍交换因子(GEF) Kalirin7和kalirin9与p75结合。Kalirin7包含Rac GEF域,而Kalirin9同时包含Rac和Rho GEF域。具体目的包括:(1)确定Kalirin7短暂激活Rac的机制;(2)确定细胞凋亡是否需要持续的Rac激活;(3)确定Kalirin9是否负责调节p75在脊髓损伤后体外和体内对Rho活性的相反作用。本研究的结果将通过阐明p75和Trk以及p75和NgR之间复杂相互作用背后的基本生化机制,从而显著提高当前对NGF信号传导的认识。对其机制的详细了解可能最终促使在神经元损伤和疾病的情况下促进再生和限制变性的治疗策略。

项目成果

期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Changes in Spontaneous firing patterns of cerebellar Purkinje cells in p75 knockout mice.
p75 敲除小鼠小脑浦肯野细胞自发放电模式的变化。
  • DOI:
    10.1007/s12311-012-0439-6
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Tian,Jinbin;Tep,Chhavy;Zhu,MichaelX;Yoon,SungOk
  • 通讯作者:
    Yoon,SungOk
The role of ErbB2 signaling in the onset of terminal differentiation of oligodendrocytes in vivo.
ErbB2 信号传导在体内少突胶质细胞终末分化开始中的作用。
EphrinB2 controls vessel pruning through STAT1-JNK3 signalling.
  • DOI:
    10.1038/ncomms7576
  • 发表时间:
    2015-03-26
  • 期刊:
  • 影响因子:
    16.6
  • 作者:
    Salvucci, Ombretta;Ohnuki, Hidetaka;Maric, Dragan;Hou, Xu;Li, Xuri;Yoon, Sung Ok;Segarra, Marta;Eberhart, Charles G.;Acker-Palmer, Amparo;Tosato, Giovanna
  • 通讯作者:
    Tosato, Giovanna
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUNG OK YOON其他文献

SUNG OK YOON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUNG OK YOON', 18)}}的其他基金

Regulation of apoptosis and degeneration after spinal cord injury
脊髓损伤后细胞凋亡和变性的调控
  • 批准号:
    7575119
  • 财政年份:
    2007
  • 资助金额:
    $ 32.78万
  • 项目类别:
Regulation of apoptosis and degeneration after spinal cord injury
脊髓损伤后细胞凋亡和变性的调控
  • 批准号:
    7361344
  • 财政年份:
    2007
  • 资助金额:
    $ 32.78万
  • 项目类别:
Regulation of apoptosis and degeneration after spinal cord injury
脊髓损伤后细胞凋亡和变性的调控
  • 批准号:
    7257628
  • 财政年份:
    2007
  • 资助金额:
    $ 32.78万
  • 项目类别:
Crosstalk between NGS Receptors, TrkA & P75
NGS 受体之间的串扰,TrkA
  • 批准号:
    7418936
  • 财政年份:
    2000
  • 资助金额:
    $ 32.78万
  • 项目类别:
CROSSTALK BETWEEN NGF RECEPTORS, TRK A AND P75
NGF 受体、TRK A 和 P75 之间的串扰
  • 批准号:
    6559243
  • 财政年份:
    2000
  • 资助金额:
    $ 32.78万
  • 项目类别:
CROSSTALK BETWEEN NGF RECEPTORS, TRK A AND P75
NGF 受体、TRK A 和 P75 之间的串扰
  • 批准号:
    6285871
  • 财政年份:
    2000
  • 资助金额:
    $ 32.78万
  • 项目类别:
CROSSTALK BETWEEN NGF RECEPTORS, TRK A AND P75
NGF 受体、TRK A 和 P75 之间的串扰
  • 批准号:
    6617994
  • 财政年份:
    2000
  • 资助金额:
    $ 32.78万
  • 项目类别:
CROSSTALK BETWEEN NGF RECEPTORS, TRK A AND P75
NGF 受体、TRK A 和 P75 之间的串扰
  • 批准号:
    6394290
  • 财政年份:
    2000
  • 资助金额:
    $ 32.78万
  • 项目类别:
CROSSTALK BETWEEN NGF RECEPTORS, TRK A AND P75
NGF 受体、TRK A 和 P75 之间的串扰
  • 批准号:
    6529609
  • 财政年份:
    2000
  • 资助金额:
    $ 32.78万
  • 项目类别:
Crosstalk between NGS Receptors, TrkA & P75
NGS 受体之间的串扰,TrkA
  • 批准号:
    7015045
  • 财政年份:
    1999
  • 资助金额:
    $ 32.78万
  • 项目类别:

相似国自然基金

Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 批准年份:
    2020
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 批准年份:
    2017
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 批准年份:
    2016
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 批准年份:
    2014
  • 资助金额:
    73.0 万元
  • 项目类别:
    面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
  • 批准号:
    81301123
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
  • 批准号:
    81101529
  • 批准年份:
    2011
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
  • 批准号:
    39500043
  • 批准年份:
    1995
  • 资助金额:
    9.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
  • 批准号:
    10585802
  • 财政年份:
    2023
  • 资助金额:
    $ 32.78万
  • 项目类别:
Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
  • 批准号:
    10719415
  • 财政年份:
    2023
  • 资助金额:
    $ 32.78万
  • 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
  • 批准号:
    10605856
  • 财政年份:
    2023
  • 资助金额:
    $ 32.78万
  • 项目类别:
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
  • 批准号:
    23K08773
  • 财政年份:
    2023
  • 资助金额:
    $ 32.78万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
  • 批准号:
    23K15866
  • 财政年份:
    2023
  • 资助金额:
    $ 32.78万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
  • 批准号:
    10743485
  • 财政年份:
    2023
  • 资助金额:
    $ 32.78万
  • 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
  • 批准号:
    10749797
  • 财政年份:
    2023
  • 资助金额:
    $ 32.78万
  • 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
  • 批准号:
    22K09076
  • 财政年份:
    2022
  • 资助金额:
    $ 32.78万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
  • 批准号:
    10583516
  • 财政年份:
    2022
  • 资助金额:
    $ 32.78万
  • 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
  • 批准号:
    RGPIN-2019-05371
  • 财政年份:
    2022
  • 资助金额:
    $ 32.78万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了